Psychiatric Drugs Explained offers a wealth of evidence-based information on psychiatric drugs in an easy-to-use format that can be quickly referenced in the clinical setting.
Written by internationally recognised author Dr David Healy, the book provides a comprehensive review of drug effects, action and side-effects. There is an emphasis on the lived experience of patients, providing the reader with a sense of what the adverse effects of drugs might feel like to those who use them.
A reader-friendly approach and clear layout, with information organised by disorder, make this popular title accessible and useful not only to nursing staff, but to all members of the multidisciplinary team.
1. Introduction - p. xi 2. 1. The person on treatment - p. 1 3. Section 1: Management of the Psychoses - p. 5 4. 2. The antipsychotics - p. 7 5. 3. Antipsychotic side effects and their management - p. 27 6. Section 2: Management of Depression - p. 47 7. 4. The antidepressants - p. 49 8. 5. Side effects of antidepressants - p. 67 9. Section 3: Management of Bipolar Disorders - p. 85 10. 6. Management of acute bipolar disorder - p. 87 11. 7. Mood-stabilisers - p. 97 12. Section 4: Psychotropic Drugs For Children - p. 119 13. 8. Stimulants and drugs for children - p. 121 14. Section 5: Management of Anxiety - p. 137 15. 9. The anxiety disorders - p. 139 16. 10. Benzodiazepine and gabapentinoid anxiolytics - p. 149 17. 11. Serotonin and anxiolysis - p. 163 18. 12. Beta-blockers and anxiety - p. 169 19. Section 6: Management of Sleep Disorders and Insomnia - p. 175 20. 13. Sleep disorders and insomnia - p. 177 21. 14. Non-pharmacological management of insomnia - p. 183 22. 15. Hypnotics - p. 187 23. 16. Sedatives - p. 193 24. Section 7: Management of Cognitive Impairment - p. 199 25. 17. Cognitive enhancement and the dementias - p. 201 26. 18. Cognitive enhancement and neuroprotection - p. 205 27. Section 8: Management of Sexual Difficulties - p. 215 28. 19. The range of sexual difficulties - p. 217 29. 20. Effects of drugs on aspects of sexual functioning - p. 223 30. Section 9: Management of Dependence and Withdrawal - p. 243 31. 21. Dependence and withdrawal - p. 245 32. 22. Dependence and craving - p. 253 33. 23. Dependence and protracted withdrawal - p. 261 34. Section 10: Consent, Abuse And Liability - p. 271 35. 24. Consent - p. 273 36. 25. Pharmacological abuse - p. 283 37. Section 11: The Marketing Of Tranquillity - p. 293 38. 26. The ethical industry - p. 295 39. 27. Evidence-biased care - p. 301 40. 28. Marketing and risk - p. 311 41. 29. From healthcare to pharmageddon - p. 319 42. Index - p. 325
Psychiatric Drugs Explained offers a wealth of evidence-based information on psychiatric drugs in an easy-to-use format that can be quickly referenced in the clinical setting.
Written by internationally recognised author Dr David Healy, the book provides a comprehensive review of drug effects, action and side-effects. There is an emphasis on the lived experience of patients, providing the reader with a sense of what the adverse effects of drugs might feel like to those who use them.
A reader-friendly approach and clear layout, with information organised by disorder, make this popular title accessible and useful not only to nursing staff, but to all members of the multidisciplinary team.
1. Introduction - p. xi 2. 1. The person on treatment - p. 1 3. Section 1: Management of the Psychoses - p. 5 4. 2. The antipsychotics - p. 7 5. 3. Antipsychotic side effects and their management - p. 27 6. Section 2: Management of Depression - p. 47 7. 4. The antidepressants - p. 49 8. 5. Side effects of antidepressants - p. 67 9. Section 3: Management of Bipolar Disorders - p. 85 10. 6. Management of acute bipolar disorder - p. 87 11. 7. Mood-stabilisers - p. 97 12. Section 4: Psychotropic Drugs For Children - p. 119 13. 8. Stimulants and drugs for children - p. 121 14. Section 5: Management of Anxiety - p. 137 15. 9. The anxiety disorders - p. 139 16. 10. Benzodiazepine and gabapentinoid anxiolytics - p. 149 17. 11. Serotonin and anxiolysis - p. 163 18. 12. Beta-blockers and anxiety - p. 169 19. Section 6: Management of Sleep Disorders and Insomnia - p. 175 20. 13. Sleep disorders and insomnia - p. 177 21. 14. Non-pharmacological management of insomnia - p. 183 22. 15. Hypnotics - p. 187 23. 16. Sedatives - p. 193 24. Section 7: Management of Cognitive Impairment - p. 199 25. 17. Cognitive enhancement and the dementias - p. 201 26. 18. Cognitive enhancement and neuroprotection - p. 205 27. Section 8: Management of Sexual Difficulties - p. 215 28. 19. The range of sexual difficulties - p. 217 29. 20. Effects of drugs on aspects of sexual functioning - p. 223 30. Section 9: Management of Dependence and Withdrawal - p. 243 31. 21. Dependence and withdrawal - p. 245 32. 22. Dependence and craving - p. 253 33. 23. Dependence and protracted withdrawal - p. 261 34. Section 10: Consent, Abuse And Liability - p. 271 35. 24. Consent - p. 273 36. 25. Pharmacological abuse - p. 283 37. Section 11: The Marketing Of Tranquillity - p. 293 38. 26. The ethical industry - p. 295 39. 27. Evidence-biased care - p. 301 40. 28. Marketing and risk - p. 311 41. 29. From healthcare to pharmageddon - p. 319 42. Index - p. 325
